Profiles people listing in a scrolling container.
  1. Home
  2. Faculty

Allison Lorenzen, MD

Clinical Assistant Professor of Surgery - Plastic and Reconstructive Surgery

Current Positions

  • Clinical Assistant Professor of Surgery- Plastic and Reconstructive Surgery

Education

  • B.A. in Biology & Psychology (summa cum laude), Wartburg College
  • M.D., University of Iowa Carver College of Medicine
  • Surgical Oncology Research Fellowship, University of Iowa
  • Residency, General Surgery, University of Iowa
  • Residency, Plastic Surgery, University of Texas Southwestern
  • MD, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
  • BA in Biology & Psychology, Wartburg College, Waverly, Iowa, United States
  • Resident in Plastic Surgery, University of Texas Southwestern, Dallas, Texas, United States
  • Resident in General Surgery, University of Iowa, Iowa City, Iowa, United States

Licenses & Certifications

  • American Board of Surgery
  • Iowa Medical License, Iowa.
  • Board Certified, American Board of Surgery

Selected Publications

  • Spanheimer PM, Bashir A, Lorenzen AW, Beck AC, Liao J, Lizarraga IM, Erdahl LM, Sugg SL, Karwal MW, Weigel RJ.  (2021). A pilot study of preoperative Vandetanib on markers of proliferation and apoptosis in breast cancer.  American Journal of Clinical Oncology, 44(9); 456-462.
  • Gu VW, Cho E, Thompson DT, Cassady VC, Borcherding N, Koch KE, Wu VT, Lorenzen AW, van der Heide, DM, White JR, Kulak MV, Williams T, Zhang W, Weigel RJ. (2021). AP-2g is required for maintenance of multipotent mammary stem cells.  Stem Cell Reports, 16(1); 106-119.
  • Lorenzen AW, Kiriazov B, De Andrade JP, Lizarraga IM, Scott-Conner CE, Sugg SL, Erdahl LM, Sun W, Weigel RJ.  (2018). Intraoperative radiotherapy for breast cancer treatment in a rural community.  Annals of Surgical Oncology, 25(10); 3004-3010.
  • De Andrade JP*, Lorenzen AW*, Wu VT, Bogacheck MV, Park JM, Gu VW, Sevenich CM, Cassady VC, Beck AC, Kulak MV, Robinson RA, Lal G, Weigel RJ.  (2017). Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.  Oncotarget, 8(70); 114801-114815. *Authors contributed equally to this work
  • Wu VT, Lorenzen AW, Beck AC, Reid VJ, Sugg SL, Howe JR, Pollard JH, Lal G, Weigel RJ.  (2017).  Comparative analysis of radioactive iodine versus thyroidectomy for definitive treatment of Graves disease.  Surgery, 161(1); 147-155.
  • Bogachek MV, Park JM, De Andrade JP, Lorenzen AW, Kulak MV, White JR, Gu VW, Wu VT, Weigel RJ.  (2016). Inhibiting the SUMO pathway represses the cancer stem cell population in breast and colorectal carcinomas.  Stem Cell Reports, 7(6); 1140-1151
  • De Andrade JP, Park JM, Gu VW, Woodfield GW, Kulak MV, Lorenzen AW, Wu VT, Van Dorin SE, Spanheimer PM, Weigel RJ. (2016).  EGFR is regulated by TFAP2C in luminal breast cancer and is a target for Vandetanib.  Molecular Cancer Therapeutics, 15(3); 503-11.
  • Spanheimer PM, Lorenzen AW, De Andrade JP, Kulak MV, Carr JC, Woodfield GW, Sugg SL, Weigel RJ. (2015). Receptor tyrosine kinase expression predicts response to sunitinib in breast cancer.  Annals of Surgical Oncology, 22(13); 4287-94.
  • Lorenzen AW, Sherman SK, Rosenbaum M, Kapadia MR.  (2014). Resident involvement in postoperative conversations: An underused opportunity.  Journal of Surgical Research, 190(2); 437-44.
  • Lorenzen AW, O’Dorisio TM, Howe JR.  (2013).  Neuroendocrine tumors arising in Meckel’s diverticula: Frequency of advanced disease warrants aggressive management.  Journal of Gastrointestinal Surgery, 17 (6); 1084-91.